MODERN APPROACHES TO THE CHOICE OF THERAPY OF LOCALLY ADVANCED AND RECURRENT/ METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA: WHAT IS THE BASIS FOR THE CHOICE OF THERAPY IN CLINICAL PRACTICE?


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

This article presents the main approaches to the choice of treatment tactics for locally advanced and recurrent/metastatic head and neck squamous cell carcinoma. The potentials for the use of the targeted drug - epidermal growth factor inhibitor, cetuximab, in clinical practice are discussed.

Толық мәтін

Рұқсат жабық

Авторлар туралы

S. Kutukova

City Clinical Oncological Dispensary; I.P. Pavlov FSPbSMU

Email: dr.s.kutukova@gmail.com
MD, oncologist; Associate Professor at the Department of Surgical Dentistry and Maxillofacial Surgery St. Petersburg

Әдебиет тізімі

  1. Состояние онкологической помощи населению России в 2016 году/ Под ред. А.Д. Каприн А., В.В. Старинского, ГВ. Петровой. М., 2017. 236 с.
  2. Head and Neck Cancer. NCCN Clinical Practice Guidelines in Oncology, ver. 1.2018. 219 p.
  3. Lo T.C.M., Wiley A.L., Ansfield F.J., et al. Combined radiationtherapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized study Am. J. Roentgenol. 1976;126:229-35.
  4. Sanchiz F., Millâ A., Torner J., et al. Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 1990;19:1347-50.
  5. Fu K.K., Phillips T.L., Silverberg I.J., et al. Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial. J. Clin. Oncol. 1987;5:1410-18.
  6. Eschwege F., Sancho-Garnier H., Gerard J.Р., et al. Ten-year results of randomized trial comparing radiotherapy and concomitant bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx: experience of the European Organization for Research and Treatment of Cancer. NCI. Monogr. 1988;6:275-78.
  7. Marcial V.A., Pajak T.F., Mohiuddin M., et al. Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Cancer 1990;66:1861-68.
  8. Haselow R.E., Warshaw M.G., Oken M.M., et al. Radiation alone versus radiation with weekly low dose ciplatinum in unresectable cancer of the head and neck cancer. In: Fee W.E., Jr, Goepfert H., Johns M.E., et al., eds. Head and Neck Cancer, vol II. Philadelphia: J.B. LippincotT., 1990. Р 279-81.
  9. Adelstein D.J., Li Y., Adams G.L., et al. An Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J. Clin. Oncol. 2003;21:92-8.
  10. Calais G.,Alfonsi M.,Bardet E.,et al.Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J. Natl. Cancer. Inst. 1999;91:2081-86.
  11. Denis F., Garaud Р., Bardet E., et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced stage oropharynx carcinoma. J. Clin. Oncol. 2004;22:69-76.
  12. Vermorken J.B., et al. Erbitux SmPC, June 2014. N. Engl. J. Med. 2008;359:1116-127.
  13. Гарин А.М., Базин И.С., Насырова Р.Ю. Эрбитукс -рационально созданный препарат для лечения злокачественных опухолей. Совр. онкология. 2007;9(4):65-8.
  14. Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of head and neck. N. Engl. J. Med. 2006;354 (6):567-78.
  15. Wolf G.T., Hong W.K., Fisher S.G., et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N. Engl. J. Med. 1991;324:1685-90.
  16. Lefebvre J.L., Chevalier D., Luboinski B., et al. Larynxpreservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J. Natl. Cancer Inst. 1996;88:890-99.
  17. Forastiere A.A., Goepfert H., Maor M., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N. Engl. J. Med. 2003;349:2091-98.
  18. lefebvre J.L., Pointreau Y., Rolland F. et al. Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study J. Clin. Oncol. 2013;31:853-59.
  19. Практические рекомендации по лечению опухолей головы и шеи. Практические рекомендации RUSSCO, Версия 2017. С. 66-76.
  20. Клинические рекомендации по лечению опухолей головы и шеи. http://oncology-association.ru/ clinical-guidelines
  21. Assessment report of Erbitux. Procedure No. EMEA/ H/C/558/II/0026. 2008. P 19.
  22. Fuchs H., Pammer J., Minichsdorfer C., et al. Modified biweekly cisplatin, docetaxel plus cetuximab (TPEx) as first-line treatment for patients with recurrent/ metastatic head and neck cancer. Med. Oncology 2018;35(3):32. doi: 10.1007/s12032-018-1087-6.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2018

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>